282 related articles for article (PubMed ID: 27795303)
1. Antibody-Based Immunotherapy To Treat and Prevent Infection with Hypervirulent Klebsiella pneumoniae.
Diago-Navarro E; Calatayud-Baselga I; Sun D; Khairallah C; Mann I; Ulacia-Hernando A; Sheridan B; Shi M; Fries BC
Clin Vaccine Immunol; 2017 Jan; 24(1):. PubMed ID: 27795303
[TBL] [Abstract][Full Text] [Related]
2. Novel, Broadly Reactive Anticapsular Antibodies against Carbapenem-Resistant Klebsiella pneumoniae Protect from Infection.
Diago-Navarro E; Motley MP; Ruiz-Peréz G; Yu W; Austin J; Seco BMS; Xiao G; Chikhalya A; Seeberger PH; Fries BC
mBio; 2018 Apr; 9(2):. PubMed ID: 29615497
[TBL] [Abstract][Full Text] [Related]
3. A promising bioconjugate vaccine against hypervirulent
Feldman MF; Mayer Bridwell AE; Scott NE; Vinogradov E; McKee SR; Chavez SM; Twentyman J; Stallings CL; Rosen DA; Harding CM
Proc Natl Acad Sci U S A; 2019 Sep; 116(37):18655-18663. PubMed ID: 31455739
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Diabetic and Non-diabetic Human Leukocytic Responses to Different Capsule Types of
Lee IR; Sng E; Lee KO; Molton JS; Chan M; Kalimuddin S; Izharuddin E; Lye DC; Archuleta S; Gan YH
Front Cell Infect Microbiol; 2017; 7():401. PubMed ID: 28936426
[TBL] [Abstract][Full Text] [Related]
5. The Role of IgG Subclass in Antibody-Mediated Protection against Carbapenem-Resistant Klebsiella pneumoniae.
Motley MP; Diago-Navarro E; Banerjee K; Inzerillo S; Fries BC
mBio; 2020 Sep; 11(5):. PubMed ID: 32900809
[TBL] [Abstract][Full Text] [Related]
6. Targeting subcapsular antigens for prevention of Klebsiella pneumoniae infections.
Clements A; Jenney AW; Farn JL; Brown LE; Deliyannis G; Hartland EL; Pearse MJ; Maloney MB; Wesselingh SL; Wijburg OL; Strugnell RA
Vaccine; 2008 Oct; 26(44):5649-53. PubMed ID: 18725260
[TBL] [Abstract][Full Text] [Related]
7. Resistance of hypervirulent Klebsiella pneumoniae to both intracellular and extracellular killing of neutrophils.
Wang L; Shen D; Wu H; Ma Y
PLoS One; 2017; 12(3):e0173638. PubMed ID: 28282434
[TBL] [Abstract][Full Text] [Related]
8. [Clinical characteristics in patients with hypervirulent Klebsiella pneumoniae infection and its capsular serotypes and multilocus sequence typing].
Yu CP; Wang S; Tian SF; Chu YZ; Chen BY
Zhonghua Nei Ke Za Zhi; 2019 May; 58(5):361-365. PubMed ID: 31060144
[No Abstract] [Full Text] [Related]
9. Patient-Derived Antibody Data Yields Development of Broadly Cross-Protective Monoclonal Antibody against ST258 Carbapenem-Resistant
Banerjee K; Motley MP; Boniche-Alfaro C; Bhattacharya S; Shah R; Ardizzone A; Fries BC
Microbiol Spectr; 2022 Aug; 10(4):e0176022. PubMed ID: 35862974
[TBL] [Abstract][Full Text] [Related]
10. Bacteremia and other body site infection caused by hypervirulent and classic Klebsiella pneumoniae.
Wu H; Li D; Zhou H; Sun Y; Guo L; Shen D
Microb Pathog; 2017 Mar; 104():254-262. PubMed ID: 28132768
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibody against Klebsiella capsular polysaccharide reduces severity and hematogenic spread of experimental Klebsiella pneumoniae pneumonia.
Held TK; Trautmann M; Mielke ME; Neudeck H; Cryz SJ; Cross AS
Infect Immun; 1992 May; 60(5):1771-8. PubMed ID: 1563764
[TBL] [Abstract][Full Text] [Related]
12. Identification of Biomarkers for Differentiation of Hypervirulent Klebsiella pneumoniae from Classical K. pneumoniae.
Russo TA; Olson R; Fang CT; Stoesser N; Miller M; MacDonald U; Hutson A; Barker JH; La Hoz RM; Johnson JR
J Clin Microbiol; 2018 Sep; 56(9):. PubMed ID: 29925642
[TBL] [Abstract][Full Text] [Related]
13. Immune stealth-driven O2 serotype prevalence and potential for therapeutic antibodies against multidrug resistant Klebsiella pneumoniae.
Pennini ME; De Marco A; Pelletier M; Bonnell J; Cvitkovic R; Beltramello M; Cameroni E; Bianchi S; Zatta F; Zhao W; Xiao X; Camara MM; DiGiandomenico A; Semenova E; Lanzavecchia A; Warrener P; Suzich J; Wang Q; Corti D; Stover CK
Nat Commun; 2017 Dec; 8(1):1991. PubMed ID: 29222409
[TBL] [Abstract][Full Text] [Related]
14. Endotoxin neutralization by an O-antigen specific monoclonal antibody: A potential novel therapeutic approach against Klebsiella pneumoniae ST258.
Szijártó V; Guachalla LM; Hartl K; Varga C; Badarau A; Mirkina I; Visram ZC; Stulik L; Power CA; Nagy E; Nagy G
Virulence; 2017 Oct; 8(7):1203-1215. PubMed ID: 28103139
[TBL] [Abstract][Full Text] [Related]
15. Target-Agnostic Identification of Functional Monoclonal Antibodies Against Klebsiella pneumoniae Multimeric MrkA Fimbrial Subunit.
Wang Q; Chang CS; Pennini M; Pelletier M; Rajan S; Zha J; Chen Y; Cvitkovic R; Sadowska A; Heidbrink Thompson J; Yu Lin H; Barnes A; Rickert K; Wilson S; Stover CK; Dall'Acqua WF; Chowdhury PS; Xiao X
J Infect Dis; 2016 Jun; 213(11):1800-8. PubMed ID: 26768253
[TBL] [Abstract][Full Text] [Related]
16. Hypervirulent Klebsiella pneumoniae induced ventilator-associated pneumonia in mechanically ventilated patients in China.
Yan Q; Zhou M; Zou M; Liu WE
Eur J Clin Microbiol Infect Dis; 2016 Mar; 35(3):387-96. PubMed ID: 26753990
[TBL] [Abstract][Full Text] [Related]
17. Increasing occurrence of antimicrobial-resistant hypervirulent (hypermucoviscous) Klebsiella pneumoniae isolates in China.
Li W; Sun G; Yu Y; Li N; Chen M; Jin R; Jiao Y; Wu H
Clin Infect Dis; 2014 Jan; 58(2):225-32. PubMed ID: 24099919
[TBL] [Abstract][Full Text] [Related]
18. Klebsiella pneumoniae type 3 fimbria-mediated immunity to infection in the murine model of respiratory disease.
Lavender H; Jagnow JJ; Clegg S
Int J Med Microbiol; 2005 Jun; 295(3):153-9. PubMed ID: 16047414
[TBL] [Abstract][Full Text] [Related]
19. Protective Role of Kupffer Cells and Macrophages in Klebsiella pneumoniae-Induced Liver Abscess Disease.
Hoh CH; Tan YH; Gan YH
Infect Immun; 2019 Sep; 87(9):. PubMed ID: 31285251
[No Abstract] [Full Text] [Related]
20. Neutrophil extracellular traps (NETs)-mediated killing of carbapenem-resistant hypervirulent
Jin L; Liu Y; Jing C; Wang R; Wang Q; Wang H
Virulence; 2020 Dec; 11(1):1122-1130. PubMed ID: 32865110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
